secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001140859-23-000113
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AmerisourceBergen Q3 revenue $66.9B, EPS beat; raises FY guidance; to become Cencora
--------------------------------------------------------------------------------

- Revenue $66.9B (+11.5% YoY); GAAP EPS $2.35 vs $1.92; adjusted EPS $2.92 vs $2.62.
- Adjusted EPS guidance raised to $11.85-$11.95 from $11.70-$11.90 for fiscal 2023.
- Company to rename to Cencora and trade under ticker 'COR' on NYSE effective Aug 30, 2023.
- CEO cited strong performance and strategic investment in OneOncology during quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000114085923000113/0001140859-23-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000114085923000113/abc-20230802.htm
  HTML page:      https://secwatch.observer/filing/0001140859-23-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer